logo
Obesity will affect over half of adults in 25 years, study predicts

Obesity will affect over half of adults in 25 years, study predicts

Yahoo06-03-2025
Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much worse it could get.
A team of researchers found that in 2021, one billion men and 1.11 billion women over 25 years of age worldwide qualified as overweight or obese — twice as many as in 1990.
In 2021, more than half of the world's overweight and obese adults lived in eight countries: China (402 million), India (180 million), the U.S. (172 million), Brazil (88 million), Russia (71 million), Mexico (58 million), Indonesia (52 million), and Egypt (41 million), according to a press release.
This Disease Kills More People Than All Cancers And Accidents Combined
If the increase continues at this same pace, the study projects that more than half (57.4%) of men and 60.3% of women will be overweight or obese by 2050.
The three countries expected to have the highest rates of overweight or obesity by 2050 are China (627 million people), India (450 million) and the U.S. (214 million).
Read On The Fox News App
The study also found that by 2050, nearly one-quarter of obese adults will be 65 or older.
The researchers analyzed data from the Global Burden of Diseases, Injuries, and Risk Factors Study, spanning 204 countries and territories.
Ozempic's Health Benefits Keep Growing, But Are The Risks Worth It?
"The unprecedented global epidemic of overweight and obesity is a profound tragedy and a monumental societal failure," said lead author Professor Emmanuela Gakidou from the Institute for Health Metrics and Evaluation (IHME), University of Washington, in the release.
"Governments and the public health community can use our country-specific estimates on the stage, timing and speed of current and forecasted transitions in weight to identify priority populations experiencing the greatest burdens of obesity who require immediate intervention and treatment, and those that remain predominantly overweight and should be primarily targeted with prevention strategies."
Another finding was that "more recent generations are gaining weight faster than previous ones and obesity is occurring earlier."
This increases the risk of younger people developing obesity-related conditions like type 2 diabetes, high blood pressure, cardiovascular diseases and multiple cancers.
There were some limitations to the study, the researchers acknowledged.
"Predictions are constrained by the quantity and quality of past data as well as systemic biases from self-reported data, which are likely to remain despite attempts to correct for bias," they wrote.
They also noted that the definition of overweight and obesity is based on BMI (body mass index), "which does not account for variations in body structure across ethnic groups and subpopulations."
The study also did not take into account the effects of GLP-1 anti-obesity medications and other interventions.
Brett Osborn, a Florida neurosurgeon and longevity expert at Senolytix, called out obesity as the "single greatest modifiable threat to longevity, economic stability and national security."
"Yet, instead of confronting the problem head-on, our culture continues to coddle bad habits, normalize obesity and abandon personal responsibility," he said in a statement to Fox News Digital.
Weight Loss May Be Helped By Drinking This, Study Suggests
"This crisis is not about food deserts genetics or corporate greed — it's about choices. And we are making the wrong ones."
The obesity crisis can be linked to sedentary lifestyles, ultraprocessed foods and an "entitlement mentality that demands a pill for every problem," according to Osborn.
"The reality is simple: Obesity is caused by caloric surplus and a lack of movement," he said. "When you consistently eat more calories than you burn, you gain weight. Period."
If cases rise to the study's projections by 2050, Osborn warned that "obesity-related diseases will cripple healthcare systems worldwide."
Click Here To Sign Up For Our Health Newsletter
"The recent Lancet study projects over 1.3 billion global diabetes cases and more than two million obesity-driven cancers annually," he said. "Cardiovascular disease will double in prevalence across multiple regions, and the economic burden will exceed $4 trillion per year. This is unsustainable."
"Our healthcare system was never designed to support a world where over half the population has a preventable, self-inflicted disease."
The fight against obesity isn't about aesthetics, Osborn said — "nor is this a personal affront to overweight or categorically obese people. This is about survival."
"The world has two choices: Act aggressively now or pay an unfathomable price later," he went on.
"The time to fight obesity — relentlessly and unapologetically — is now."
For more Health articles, visit www.foxnews.com/health
The study was funded by the Bill & Melinda Gates Foundation. It was conducted by the GBD 2021 Adolescent and Adult BMI Collaborators. Fox News Digital reached out to the researchers for comment.Original article source: Obesity will affect over half of adults in 25 years, study predicts
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

It's rude to ask if someone is taking Ozempic. Here's why.
It's rude to ask if someone is taking Ozempic. Here's why.

Yahoo

timea day ago

  • Yahoo

It's rude to ask if someone is taking Ozempic. Here's why.

There's a new kind of nosy parker on the rise in the United States, a person who thinks it's fine to blurt out 'Are you on Ozempic?' to those they barely know. This is probably a reflection of how many Americans are taking this class of medications known as GLP-1 inhibitors. Twelve percent of adults in the United States have taken them at some point, according to a 2024 KFF Health Tracking Poll, and prescriptions have soared every year in the past decade. This class of medications includes tirzepatide (brand names Zepbound and Mounjaro) and semaglutide (Wegovy and Ozempic), and I know numerous friends and colleagues who take one. They have been lifesavers for many people with Type 2 diabetes or who want to lose weight for medical reasons. As with other medications, like Botox, some thorny social dilemmas have followed: Is it rude to ask if someone is taking one? And what do you say if someone asks you that question? Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. (Full disclosure: I was prescribed a GLP-1 for a cluster of medical conditions: prediabetes, insulin resistance and cardiovascular disease.) I talked to two physicians who prescribe the meds, two well-known advice columnists and two dozen GLP-1 users for their take on the big etiquette questions on the table. Here's what I learned. - - - Is it okay to ask someone if they're taking a GLP-1 inhibitor? Two years ago, I reconnected with a former colleague who'd lost so much weight I barely recognized him. My first thought was, 'Did he have cancer' or 'Was something wrong?' Lucky me, he beat me to the punch by confiding that he'd been using Ozempic. While some of those on GLP-1 inhibitors say it doesn't bother them to be asked, Randy Jones, an author and podcast host, who is currently taking one, told me: 'I absolutely don't think people should be empowered to ask someone about their medications without an invitation to do so.' Lizzie Post, the great-great-granddaughter of etiquette guru Emily Post and co-president of the institute that bears her name, agrees, explaining the medications we take and the procedures we undergo are private. 'You don't walk up to a friend and ask if they're on Botox,' she says. Bottom line: Don't ask, mostly. (And it's probably a good idea to avoid speculating on social media about celebrities' mysterious weight loss, too. It's practically a sport for some people, but that doesn't make it okay.) - - - But I want to show I care. Isn't that a good reason? Not really. Context matters, and you may not have all the details to navigate that tricky conversation without being offensive. A friend of mine, a pastor who is in front of a large congregation every Sunday, lost 52 pounds in nine months. She says she's been asked by just about everybody at one point or another, how she lost weight. While she appreciates the well-wishers who say, 'You look great! Do you feel good?' she also would prefer that people didn't make that big a deal out of it. For example, some people seem compelled to comment on her body every time they see her. 'Are you buying a whole new wardrobe?' 'You've gotten so little.' That gets under her skin because 'I don't like having my body size be the most interesting thing about me in their eyes.' David Wiss, a registered dietitian nutritionist who is based in Los Angeles and counsels patients on issues of weight and mental health, says he recommends avoiding 'body talk' of any kind. 'Body sovereignty describes the freedom and autonomy to make choices about your own body and health,' he said. Carolyn Hax, the longtime Washington Post advice columnist, says that if you're just being nosy, there's no good way to ask. But if you've struggled with weight yourself or know someone well enough to believe you can ask without giving offense, frame your question that way. Otherwise, Hax suggests, 'If people look well, look happy, look great in that color, then by all means say that.' But don't comment on their bodies. Bottom line: As I've often said, if it's curiosity that's driving you, curb it. - - - How should I respond if someone asks me this question? Matt Hughes, a town commissioner in Hillsborough, North Carolina, told me he's hesitant to make the disclosure about using a GLP-1 because 'it's almost as if someone worked less hard to lose the weight,' he said. Even if that's not your intention, asking people if they are taking a GLP-1 might be mistaken for 'Ozempic shaming,' which is when people are criticized or judged for taking a drug to lose weight rather than relying on diet and exercise, even though lifestyle changes don't work for the vast majority of people. 'Weight stigma is deeply ingrained and almost unconscious,' said Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital. She reminded me that GLP-1s are treatments for medical conditions - just like those for high blood pressure, cancer or anything else - which can empower those to reply to intrusive queries by being direct, humorous or just deflecting the question. Some snappy responses I've heard include: - 'It's none of your business.' - 'I like to keep a little mystery.' - 'Who wants to know?' - And my personal favorite: 'My weight is really not that interesting.' Bottom line: It's no one's business but your own, and you don't need to discuss your prescriptions with anyone but your doctor. - - - Are there new rules for dinner parties or sharing a restaurant tab? People who start taking GLP-1s often experience major changes in appetite or have side effects like nausea, which can limit how much they want to eat. Some people find they are less interested in drinking alcohol as well. That means in social situations, you may not be able to eat or drink like you have in the past. If you're dining at a friend's house and can't eat as much as you used to, a simple 'no, thank you' should suffice - and a considerate host won't press the issue. When dining out, there's the age-old dilemma about splitting the check: 'I only had a salad. You had a steak.' Or, 'I don't drink alcohol, and you had three cocktails.' When someone is having smaller portions or fewer courses, splitting a check can be even more difficult. Hax reminds people 'to be mindful of fairness and not hide behind expediency to get the 'sober dieting vegans' to cover their champagne and lobster.' She also suggests 'reading the room,' which means sometimes you can get separate checks, or take half of your meal home, and sometimes you just overpay, for the pleasure of everyone's company. Post also has some specific strategies, like telling friends you dine with regularly: 'Hey guys, I'm eating a lot less these days. Is it okay if I get my own check?' Or offer to use check-sharing apps like Billr or Divvy so that all diners pay what they owe. When I host, I've started asking guests not only if they have any food allergies or preferences, but also: 'Is there anything else I need to know in preparing dinner?' That allows room for someone to let me know either that they're on a GLP-1, or simply that they're only able to eat certain amounts or types of food these days. For that reason, I'm also inclined to serve buffet style, letting everyone decide how much they want on their plate. Bottom line: Be prepared to communicate your needs ahead of time and don't pry for details if a friend's eating habits change. I've faced many well-meaning but intrusive questions myself, which is why I smiled when Hax told me: 'Too bad there isn't a GLP-1 for ignorance.' Related Content Ukraine scrambles to roll back Russian eastern advance as summit takes place Her dogs kept dying, and she got cancer. Then they tested her water. D.C.'s homeless begin to see the effects of Trump's crackdown Solve the daily Crossword

It's rude to ask if someone is taking Ozempic. Here's why.
It's rude to ask if someone is taking Ozempic. Here's why.

Washington Post

timea day ago

  • Washington Post

It's rude to ask if someone is taking Ozempic. Here's why.

There's a new kind of nosy parker on the rise in the United States, a person who thinks it's fine to blurt out 'Are you on Ozempic?' to those they barely know. This is probably a reflection of how many Americans are taking this class of medications known as GLP-1 inhibitors. Twelve percent of adults in the United States have taken them at some point, according to a 2024 KFF Health Tracking Poll, and prescriptions have soared every year in the past decade. This class of medications includes tirzepatide (brand names Zepbound and Mounjaro) and semaglutide (Wegovy and Ozempic), and I know numerous friends and colleagues who take one. They have been lifesavers for many people with Type 2 diabetes or who want to lose weight for medical reasons. As with other medications, like Botox, some thorny social dilemmas have followed: Is it rude to ask if someone is taking one? And what do you say if someone asks you that question? (Full disclosure: I was prescribed a GLP-1 for a cluster of medical conditions: prediabetes, insulin resistance and cardiovascular disease.) I talked to two physicians who prescribe the meds, two well-known advice columnists and two dozen GLP-1 users for their take on the big etiquette questions on the table. Here's what I learned. Two years ago, I reconnected with a former colleague who'd lost so much weight I barely recognized him. My first thought was, 'Did he have cancer' or 'Was something wrong?' Lucky me, he beat me to the punch by confiding that he'd been using Ozempic. While some of those on GLP-1 inhibitors say it doesn't bother them to be asked, Randy Jones, an author and podcast host, who is currently taking one, told me: 'I absolutely don't think people should be empowered to ask someone about their medications without an invitation to do so.' Lizzie Post, the great-great-granddaughter of etiquette guru Emily Post and co-president of the institute that bears her name, agrees, explaining the medications we take and the procedures we undergo are private. 'You don't walk up to a friend and ask if they're on Botox,' she says. Bottom line: Don't ask, mostly. (And it's probably a good idea to avoid speculating on social media about celebrities' mysterious weight loss, too. It's practically a sport for some people, but that doesn't make it okay.) Not really. Context matters, and you may not have all the details to navigate that tricky conversation without being offensive. A friend of mine, a pastor who is in front of a large congregation every Sunday, lost 52 pounds in nine months. She says she's been asked by just about everybody at one point or another, how she lost weight. While she appreciates the well-wishers who say, 'You look great! Do you feel good?' she also would prefer that people didn't make that big a deal out of it. For example, some people seem compelled to comment on her body every time they see her. 'Are you buying a whole new wardrobe?' 'You've gotten so little.' That gets under her skin because 'I don't like having my body size be the most interesting thing about me in their eyes.' David Wiss, a registered dietitian nutritionist who is based in Los Angeles and counsels patients on issues of weight and mental health, says he recommends avoiding 'body talk' of any kind. 'Body sovereignty describes the freedom and autonomy to make choices about your own body and health,' he said. Carolyn Hax, the longtime Washington Post advice columnist, says that if you're just being nosy, there's no good way to ask. But if you've struggled with weight yourself or know someone well enough to believe you can ask without giving offense, frame your question that way. Otherwise, Hax suggests, 'If people look well, look happy, look great in that color, then by all means say that.' But don't comment on their bodies. Bottom line: As I've often said, if it's curiosity that's driving you, curb it. Matt Hughes, a town commissioner in Hillsborough, North Carolina, told me he's hesitant to make the disclosure about using a GLP-1 because 'it's almost as if someone worked less hard to lose the weight,' he said. Even if that's not your intention, asking people if they are taking a GLP-1 might be mistaken for 'Ozempic shaming,' which is when people are criticized or judged for taking a drug to lose weight rather than relying on diet and exercise, even though lifestyle changes don't work for the vast majority of people. 'Weight stigma is deeply ingrained and almost unconscious,' said Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital. She reminded me that GLP-1s are treatments for medical conditions — just like those for high blood pressure, cancer or anything else — which can empower those to reply to intrusive queries by being direct, humorous or just deflecting the question. Some snappy responses I've heard include: Bottom line: It's no one's business but your own, and you don't need to discuss your prescriptions with anyone but your doctor. People who start taking GLP-1s often experience major changes in appetite or have side effects like nausea, which can limit how much they want to eat. Some people find they are less interested in drinking alcohol as well. That means in social situations, you may not be able to eat or drink like you have in the past. If you're dining at a friend's house and can't eat as much as you used to, a simple 'no, thank you' should suffice — and a considerate host won't press the issue. When dining out, there's the age-old dilemma about splitting the check: 'I only had a salad. You had a steak.' Or, 'I don't drink alcohol, and you had three cocktails.' When someone is having smaller portions or fewer courses, splitting a check can be even more difficult. Hax reminds people 'to be mindful of fairness and not hide behind expediency to get the 'sober dieting vegans' to cover their champagne and lobster.' She also suggests 'reading the room,' which means sometimes you can get separate checks, or take half of your meal home, and sometimes you just overpay, for the pleasure of everyone's company. Post also has some specific strategies, like telling friends you dine with regularly: 'Hey guys, I'm eating a lot less these days. Is it okay if I get my own check?' Or offer to use check-sharing apps like Billr or Divvy so that all diners pay what they owe. When I host, I've started asking guests not only if they have any food allergies or preferences, but also: 'Is there anything else I need to know in preparing dinner?' That allows room for someone to let me know either that they're on a GLP-1, or simply that they're only able to eat certain amounts or types of food these days. For that reason, I'm also inclined to serve buffet style, letting everyone decide how much they want on their plate. Bottom line: Be prepared to communicate your needs ahead of time and don't pry for details if a friend's eating habits change. I've faced many well-meaning but intrusive questions myself, which is why I smiled when Hax told me: 'Too bad there isn't a GLP-1 for ignorance.'

People Share Frustrating Parts Of Today's Beauty Standards
People Share Frustrating Parts Of Today's Beauty Standards

Buzz Feed

time2 days ago

  • Buzz Feed

People Share Frustrating Parts Of Today's Beauty Standards

As women in the modern world, it's hard enough dealing with everyday pressures. But on top of that, there's the added stress of having to look a certain way — especially with social media broadcasting idealized versions of faces and bodies. Are people allowed to have fine lines and wrinkles anymore? Be in public without a stitch of makeup? Do we all need to have a perfectly slim waist, but curves in all the other right places? Have rock-hard abs and less than 20% body fat? It's a cycle of trying to find peace, then logging into social media and seeing everyone looking perfect. Ladies, it's time to share your opinon: What are the most frustrating parts of today's beauty standards? Is it the pressure to get Botox and fillers? To fall into a certain weight range with medications like GLP-1s on the rise? Will you share your frustrations with us? Share your thoughts in the comments. For those who prefer to stay anonymous, you can fill out the anonymous form below. Your response may be featured in an upcoming BuzzFeed post.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store